Marker Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. 

CEO
Juan F. Vera
CEOJuan F. Vera
Employees
5
Employees5
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
1991
Founded1991
Employees
5
Employees5

MRKR Key Statistics

Market cap
13.47M
Market cap13.47M
Price-Earnings ratio
-1.00
Price-Earnings ratio-1.00
Dividend yield
Dividend yield
Average volume
35.75K
Average volume35.75K
High today
$1.23
High today$1.23
Low today
$1.19
Low today$1.19
Open price
$1.20
Open price$1.20
Volume
29.75K
Volume29.75K
52 Week high
$5.99
52 Week high$5.99
52 Week low
$0.95
52 Week low$0.95

People also own

Based on the portfolios of people who own MRKR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.